CON-10002 Kansas City, MO Investigative Site — Kansas City, Missouri

CON-10002 Kansas City, MO Investigative Site is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

CON-10002 Kansas City, MO Investigative Site has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Heart Failure.

Sponsors: Colorado Prevention Center.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for CON-10002 Kansas City, MO Investigative Site?

CON-10002 Kansas City, MO Investigative Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has CON-10002 Kansas City, MO Investigative Site conducted?

CON-10002 Kansas City, MO Investigative Site has 1 clinical trials on record, with 1 currently active. Their work covers Heart Failure.

Is CON-10002 Kansas City, MO Investigative Site accredited by Crixeo Health?

CON-10002 Kansas City, MO Investigative Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about CON-10002 Kansas City, MO Investigative Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.